Lead Product(s) : Mirogabalin Besylate
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Tarlige® Tablets Approved in Japan for Treatment of Patients with Neuropathic Pain
Details : Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Product Name : Tarlige
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 28, 2022
Lead Product(s) : Mirogabalin Besylate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
